Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy

Overview of attention for article published in Core Evidence, December 2007

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

The effects of supervision on the outcomes of exercise training in patients with ankylosing spondylitis: A single‐blind randomized controlled trial

Article in International Journal of Rheumatic Diseases (April 2023)

Comparison of the efficacy and safety of biosimilar adalimumab injection with innovator adalimumab in subjects with active ankylosing spondylitis

Preprint in Research Square (April 2023)

Randomized, placebo controlled and double‐blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a meta‐analysis

Article in International Journal of Rheumatic Diseases (February 2014)